Alpha7 nicotinic acetylcholine receptors modulate motivation to self-administer nicotine: implications for smoking and schizophrenia.
about
Smoking cessation and reduction in people with chronic mental illnessMolecular mechanisms underlying behaviors related to nicotine addictionGlutamatergic transmission in drug reward: implications for drug addictionMenthol binding and inhibition of α7-nicotinic acetylcholine receptorsnAChR dysfunction as a common substrate for schizophrenia and comorbid nicotine addiction: Current trends and perspectives.Evaluating the role of the alpha-7 nicotinic acetylcholine receptor in the pathophysiology and treatment of schizophrenia.Compromised neuroplasticity in cigarette smokers under nicotine withdrawal is restituted by the nicotinic α4β2-receptor partial agonist varenicline.Acetylcholine as a neuromodulator: cholinergic signaling shapes nervous system function and behavior.Merging old and new perspectives on nicotinic acetylcholine receptorsNicotine uses neuron-glia communication to enhance hippocampal synaptic transmission and long-term memory.Enhancing effect of menthol on nicotine self-administration in ratsGenetic Variation of the Mu Opioid Receptor (OPRM1) and Dopamine D2 Receptor (DRD2) is Related to Smoking Differences in Patients with Schizophrenia but not Bipolar DisorderNicotine and ethanol co-use in Long-Evans rats: Stimulatory effects of perinatal exposure to a fat-rich diet.Melatonin administration alters nicotine preference consumption via signaling through high-affinity melatonin receptors.Nicotinic receptor contributions to smoking: insights from human studies and animal modelsDevelopment of novel pharmacotherapeutics for tobacco dependence: progress and future directionsIn vivo pharmacological interactions between a type II positive allosteric modulator of α7 nicotinic ACh receptors and nicotinic agonists in a murine tonic pain model.Not so Cool? Menthol's discovered actions on the nicotinic receptor and its implications for nicotine addiction.Positive allosteric modulation of α4β2 nicotinic acetylcholine receptors as a new approach to smoking reduction: evidence from a rat model of nicotine self-administration.Differential modulation of brain nicotinic acetylcholine receptor function by cytisine, varenicline, and two novel bispidine compounds: emergent properties of a hybrid molecule.Involvement of glutamatergic and GABAergic systems in nicotine dependence: Implications for novel pharmacotherapies for smoking cessation.Effects of blockade of α4β2 and α7 nicotinic acetylcholine receptors on cue-induced reinstatement of nicotine-seeking behaviour in rats.Genetic variation within the Chrna7 gene modulates nicotine reward-like phenotypes in mice.Alpha7 neuronal nicotinic receptors as a drug target in schizophrenia.Diverse strategies targeting α7 homomeric and α6β2* heteromeric nicotinic acetylcholine receptors for smoking cessation.The discriminative stimulus effects of i.v. nicotine in rhesus monkeys: Pharmacokinetics and apparent pA2 analysis with dihydro-β-erythroidine.New Targets for Schizophrenia Treatment beyond the Dopamine HypothesisA behavioral economic perspective on smoking persistence in serious mental illness.In vivo interactions between α7 nicotinic acetylcholine receptor and nuclear peroxisome proliferator-activated receptor-α: Implication for nicotine dependence.Initial Cross-Over Test of a Positive Allosteric Modulator of Alpha-7 Nicotinic Receptors to Aid Cessation in Smokers with or Without Schizophrenia.Role of the cholinesterase inhibitors in the treatment of schizophrenia.The current agonists and positive allosteric modulators of α7 nAChR for CNS indications in clinical trials.Nicotinic acetylcholine receptors in neuropathic and inflammatory pain.Attenuating Nicotine Reinforcement and Relapse by Enhancing Endogenous Brain Levels of Kynurenic Acid in Rats and Squirrel Monkeys.Unique Molecular Regulation of Higher-Order Prefrontal Cortical Circuits: Insights into the Neurobiology of Schizophrenia.Association and cis-mQTL analysis of variants in CHRNA3-A5, CHRNA7, CHRNB2, and CHRNB4 in relation to nicotine dependence in a Chinese Han population.GABAergic inhibitory neurons as therapeutic targets for cognitive impairment in schizophrenia.Pharmacological modulation of the α7 nicotinic acetylcholine receptor in a mouse model of mecamylamine-precipitated nicotine withdrawal.Current Concepts and Treatments of Schizophrenia
P2860
Q26782639-3578A9B8-8DBC-4AF7-8C89-B5C6259D3E2BQ26851972-439044D7-8119-46A6-BB39-406CD5B671BEQ28112161-3CEAFB0C-1494-46E3-BD03-C5E9A1DB67C4Q28534796-677F53D1-EC68-4732-9070-CA705E20275AQ30362464-D251FC8F-A252-4F84-BF34-DA4E5E0F4FC5Q30428422-987087D8-8B07-4642-B082-9D060E41E27FQ33684431-368577D0-8652-489A-8250-5ECCECBE5F71Q34304101-D206FCCF-75AF-4B18-9F79-025E060EC709Q34401492-469EA9B1-2B04-43EC-B247-3DFCEFB5F678Q34490857-16D0FA7B-3D23-411D-8197-340EBBC5E4D6Q34535780-53118ECB-18DF-40C7-9D1C-318F64159699Q35196495-EE9BE339-3510-48F3-A19A-C5729501F4E9Q35748436-3AA9199B-3A1A-4201-B9D6-15A42BB373FFQ35788356-7B0FB83B-3D5C-43E1-AC61-70B47AB1FF6AQ35966896-A2E1D5C0-275A-4AB9-BF87-6E8C4F563154Q36727844-D5A9AD3D-6329-4446-BF1B-D0933E9438D0Q36929434-C348B521-5262-4115-986A-F9EEABF44E33Q37039384-597F5D86-91BA-4FD7-BCE0-3DBE5DEE2327Q37230901-DC4914A2-104B-4E9A-BC74-8EB565AE25DFQ37252061-4C7106F2-9920-4515-8A35-100EDEC144FBQ37315470-9CA3AADD-5ECE-4329-840C-71FF3258D46CQ37351302-6164EFAC-6639-4733-A1C7-894A90EAD1C1Q37573968-68EAEF15-7037-4F2A-8DBB-C811D6556068Q38066550-67591255-1111-4801-B0EE-B94B055575CCQ38204497-F0A04B2C-3E6F-4861-9202-980B60F068D4Q39112269-0577A2E5-FF54-452F-B71B-8F968B1592BEQ41573540-3E6EB519-D07D-450E-86A3-CDE116A3F5BFQ42723800-AE779A2F-5992-4876-B24B-69306188AFB3Q45054305-D2240723-7C96-406C-AF24-BEE19031D0A3Q45074229-747700D5-E72A-427F-B67B-77B71CB97F06Q45377956-30AEEA9D-C162-40A1-81E1-EC22BD61D0E6Q47127039-9A8CA7F0-4A03-474D-AC77-7A45353019B4Q47739924-8C488AE1-C0FA-4A0C-B0C4-820E9EB318B0Q48332007-64B7EBEF-05F6-483D-AB5F-47C9D4281F94Q50535284-BD81EEFA-5F8A-488F-8DE7-83C06207ED27Q52582068-23B4AF73-9724-4288-9F1E-91E64DDDEA5DQ53428761-5BE7D0EA-4AA9-4848-9B5B-A35BFF890572Q53432314-41290E84-A9FF-4400-943C-95B1BB24978DQ58693044-BCBE6F75-40A8-448D-A119-24EC2E4139C5
P2860
Alpha7 nicotinic acetylcholine receptors modulate motivation to self-administer nicotine: implications for smoking and schizophrenia.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Alpha7 nicotinic acetylcholine ...... for smoking and schizophrenia.
@ast
Alpha7 nicotinic acetylcholine ...... for smoking and schizophrenia.
@en
type
label
Alpha7 nicotinic acetylcholine ...... for smoking and schizophrenia.
@ast
Alpha7 nicotinic acetylcholine ...... for smoking and schizophrenia.
@en
prefLabel
Alpha7 nicotinic acetylcholine ...... for smoking and schizophrenia.
@ast
Alpha7 nicotinic acetylcholine ...... for smoking and schizophrenia.
@en
P2860
P356
P1476
Alpha7 nicotinic acetylcholine ...... for smoking and schizophrenia.
@en
P2093
Darlene H Brunzell
J Michael McIntosh
P2860
P2888
P304
P356
10.1038/NPP.2011.299
P407
P577
2011-12-14T00:00:00Z